摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2,6-dichlorophenyl)-N'-benzoyl thiourea | 41542-10-3

中文名称
——
中文别名
——
英文名称
N-(2,6-dichlorophenyl)-N'-benzoyl thiourea
英文别名
N-(2,6-dichlorophenyl)-N’-benzoylthiourea;N-[(2,6-dichlorophenyl) carbamothioyl] benzamide;1-(2,6-dichlorophenyl)-3-benzoyl-thiourea;1-(2,6-dichlorophenyl)-3-benzoylthiourea;N'-Benzoyl-N-(2,6-dichlorphenyl)-thioharnstoff;N-[(2,6-dichlorophenyl)carbamothioyl]benzamide
N-(2,6-dichlorophenyl)-N'-benzoyl thiourea化学式
CAS
41542-10-3
化学式
C14H10Cl2N2OS
mdl
MFCD00158750
分子量
325.218
InChiKey
VNMIXZLSPNJOGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    180-181 °C
  • 密度:
    1.461±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    73.2
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2930909090

SDS

SDS:b3590e37d29fa9075c1a3070a3c969ca
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(2,6-dichlorophenyl)-N'-benzoyl thioureasodium hydroxide 作用下, 反应 0.17h, 以97%的产率得到2,6-二氯苯基硫脲
    参考文献:
    名称:
    Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas
    摘要:
    制备芳基硫脲的改进方法包括将苯甲酰异硫氰酸酯与苯胺在丙酮中反应,然后用5%氢氧化钠水溶液对生成的N-芳基-N'-苯甲酰硫脲进行去苯甲酰化。双环烷基硫脲和N-(芳烷基)硫脲(例如9H-9-芴基硫脲)可直接由相应的异硫氰酸酯与氨反应制备。
    DOI:
    10.1055/s-1988-27605
  • 作为产物:
    描述:
    苯甲酸氯化亚砜 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 0.17h, 生成 N-(2,6-dichlorophenyl)-N'-benzoyl thiourea
    参考文献:
    名称:
    Solution-phase microwave assisted parallel synthesis of N,N′-disubstituted thioureas derived from benzoic acid: Biological evaluation and molecular docking studies
    摘要:
    An efficient and facile microwave-assisted solution phase parallel synthesis for a 26-member library of N,N'-disubstituted thiourea analogs were accomplished successfully. The reaction time for synthesis of analogs was drastically reduced from a reported 8-12 h to only 10 min. Compounds were more than 95% pure, as characterized by modern analytical techniques, i.e. H-1 & C-13 NMR and FT-IR. The solid phase structural analysis has also been performed by single crystal XRD analysis. Synthesized compounds were preliminary screened for their in vitro urease inhibition and antifungal activity. Most of the compounds were found to be potent inhibitors of urease. However, the most significant activity was found for 11 with IC50 of 1.67 mu M. The docking scores correlate with the IC50 values of inhibitors. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.10.012
点击查看最新优质反应信息

文献信息

  • Synergism of fused bicyclic 2-aminothiazolyl compounds with polymyxin B against <i>Klebsiella pneumoniae</i>
    作者:Rong Wang、Shuang Hou、Xiaojing Dong、Daijie Chen、Lei Shao、Liujia Qian、Zhong Li、Xiaoyong Xu
    DOI:10.1039/c7md00354d
    日期:——

    A series of fused bicyclic 2-aminothiazolyl compounds were synthesized and evaluated for their synergistic effects with polymyxin B (PB) against Klebsiella pneumoniae (SIPI-KPN-1712).

    一系列融合的双环2-氨基噻唑基化合物被合成并评估其与多粘菌素B(PB)对抗肺炎克雷伯菌(SIPI-KPN-1712)的协同效应。
  • Guanidines
    申请人:William H. Rorer, Inc.
    公开号:US03976643A1
    公开(公告)日:1976-08-24
    Novel substituted phenylquanidine compounds and processes for their preparation are disclosed. Their use as anti-hypertensive agents is also revealed.
    揭示了一种新型的取代苯基喹啉胺化合物及其制备方法。同时还揭示了它们作为降压药物的用途。
  • Method of preparing 2-(phenylamino)-imidazolines-(2)
    申请人:DSO "Pharmachim"
    公开号:US04290971A1
    公开(公告)日:1981-09-22
    A process for preparing compounds of the formula: ##STR1## or pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 each individually are hydrogen, halogen, or nitro, which comprises the steps of: (a) alkylating a compound of the formula: ##STR2## wherein R.sub.3 is C.sub.1 to C.sub.4 alkyl or phenyl, with a compound of the formula: R.sub.4 --X wherein R.sub.4 is C.sub.1 to C.sub.6 alkyl or phenyl-alkyl where the alkyl is C.sub.1 to C.sub.4 and X is halogen, in the presence of a base to yield a compound of the formula: ##STR3## and; (b) cyclizing the compound formed during step (a) with ethylenediamine mono-p-toluenesulphonate at a temperature of 100.degree. to 200.degree. C. to yield the desired product. New intermediate compounds are also disclosed. The desired products have antihypertensive properties.
    制备式为:##STR1## 或其药学上可接受的盐的化合物的方法,其中R.sub.1和R.sub.2各自独立地为氢、卤素或硝基,包括以下步骤:(a)用式为:##STR2##其中R.sub.3为C.sub.1至C.sub.4烷基或苯基,与式为:R.sub.4 --X的化合物进行烷基化反应,其中R.sub.4为C.sub.1至C.sub.6烷基或苯基-烷基,烷基为C.sub.1至C.sub.4,X为卤素,在碱存在下得到式为:##STR3##的化合物;(b)将步骤(a)中形成的化合物与乙二胺单-p-甲苯磺酸盐在100℃至200℃的温度下环化,得到所需的产物。还公开了新的中间体化合物。所得的产物具有降压作用。
  • Synthesis, single crystal X-ray, Hirshfeld surface analysis and characterization of novel 4-(2,4-dichlorophenyl)-N-(2,6-dichlorophenyl)-1,3-thiazol-2-amine
    作者:B.H. Gayathri、Jagadeesh Prasad Dasappa、N.R. Bhavya、Chandra、M. Mahendra
    DOI:10.1016/j.molstruc.2017.05.126
    日期:2017.10
    thiazole scaffold was studied. The formation of title compound 4-(2,4-dichlorophenyl)-N-(2,6-dichlorophenyl)-1,3-thiazol-2-amine(6) was evidenced through the changes in FTIR, 1H NMR, LCMS Data. The X-ray diffraction studies revealed that compound (6) crystallized in monoclinic crystal system with P21/c Space group with Z = 4. The percentage of intermolecular contacts contributing to the Hirshfeld surface
    摘要 在本研究中,研究了一种新型噻唑支架的光谱表征。通过FTIR、1H NMR、LCMS数据的变化证明标题化合物4-(2,4-二氯苯基)-N-(2,6-二氯苯基)-1,3-噻唑-2-胺(6)的形成. X 射线衍射研究表明,化合物 (6) 在 Z = 4 的 P21/c 空间群的单斜晶系中结晶。通过使用 2D 指纹的 Hirshfeld 表面分析解决了噻唑晶体中 Hirshfeld 表面的分子间接触百分比地块。
  • Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties
    作者:Shahida Parveen、Kelvin K. H. Tong、Muhammad Khawar Rauf、Mario Kubanik、Muhammad Ashraf Shaheen、Tilo Söhnel、Stephen M. F. Jamieson、Muhammad Hanif、Christian G. Hartinger
    DOI:10.1002/asia.201801798
    日期:2019.4.15
    involving the S donor atom and surprisingly in bidentate coordination mode a deprotonated thiourea nitrogen resulting in a 4‐membered ring structure around the metal center. DFT calculations were used to explain the differences in coordination behavior. These were complemented by stability studies and biological investigations of the compounds as anticancer agents. Several of the synthesized derivatives
    苯甲硫脲衍生物的特征是几个能够与金属中心配位的供体原子。我们在这里报告了一系列的Ru(η 6 - p-苯甲基)配合物,采用苯甲酰基硫脲衍生物作为配体。此类配体通常通过其S和O供体原子与金属中心配位。我们分离出了复杂的配体,其中配体与Ru涉及S供体原子单配或双齿配位,而出乎意料的是,在双齿配位模式下,去质子化的硫脲氮在金属中心周围形成4元环结构。DFT计算被用来解释协调行为的差异。这些都得到了该化合物作为抗癌药的稳定性研究和生物学研究的补充。几种合成的衍生物表现出显着的细胞生长抑制活性,具有双齿配体的复合物比其单齿配体更有效。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐